The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
about
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligandsThe putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoInternational Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsReceptors for acylethanolamides-GPR55 and GPR119Endocannabinoids as Guardians of MetastasisLysophosphatidylinositol Signalling and Metabolic DiseasesVascular targets for cannabinoids: animal and human studiesCB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune DysregulationPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertilityG protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and laminationThe natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonistsMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Pharmacological characterization of GPR55, a putative cannabinoid receptorIdentification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.CB2: a cannabinoid receptor with an identity crisisThe endocannabinoid system as a target for the treatment of neurodegenerative disease.GPR55 ligands promote receptor coupling to multiple signalling pathways.A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediatorNovel lysophosphoplipid receptors: their structure and function.Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists.Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signallingGPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils.Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.The therapeutic potential of orphan GPCRs, GPR35 and GPR55.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.A role for GPR55 in human placental venous endothelial cells.The endocannabinoid system: an overview.The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.Molecular Targets of Cannabidiol in Neurological DisordersPeptide-guided targeting of GPR55 for anti-cancer therapy.GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
P2860
Q24311776-DDA36444-9888-40E2-8F15-8836C8BEF9CAQ24322122-B77B74C0-34C2-4B20-9039-B7C6CD177A00Q24605072-4B3C4445-0B08-4628-8793-CCDF9F9CCC81Q24647538-B356761E-BEE0-4631-8B19-17049520CF57Q26766163-26CFEDFC-8C1C-4581-AC65-B7362EFCBBDFQ26771102-5EC512CB-D73E-4F3B-94FF-866B89895B57Q26862515-6B569851-891F-426A-B826-D2DA2DF13B80Q28072822-7A20D9AC-D9AF-4B6D-A571-01043A717C23Q28286551-9509CE68-64A7-4670-B924-341E1C210A4EQ28298445-B509CAF3-2C33-4249-993E-0397023902ACQ28303095-9E5A87A0-3878-461D-B543-E8A57D920D73Q28512264-ADC78F33-6D60-4FC6-A945-82CB585CF5FAQ28534752-992EB08D-E8FC-402E-A90F-54D471F3AFF8Q33636763-ECF83253-0871-4D27-9682-73F51C94D12BQ33869340-AD0398FA-2D34-4C73-8397-C47004AC4D6FQ33887246-C386570B-C78C-4A2A-ACE0-97106B4E28A8Q34014550-20C36937-C55F-41EB-8F86-7AE994273D4FQ34070354-D3EAC8BA-2657-4CD2-877A-ADA2223F1EFCQ34098185-05EFB0F4-C1AF-4BB9-9205-FE2AAD94F918Q34098196-179115E8-E558-4C78-9E68-CFD87026ACC4Q34098246-D9B9428B-C589-4D51-8924-CCE4B5C45EB3Q34098297-CF36B9F6-56E5-4096-8DAE-8D6750FBC346Q34116761-639DFA0F-4D62-453B-9B56-1048F10101EAQ34238610-272B38F0-B35C-437A-87B1-D229A1056D53Q34453695-CFDDDA44-053F-481F-9E09-A216E887E94BQ34953430-7FB613DB-013A-4229-AF51-2528B53199D3Q35094180-45244BD0-72F0-48F4-B8BB-83A34D76B146Q35357827-9BE71F2B-F14F-4783-B7B8-A9CB350EBDDCQ35425244-B1FAB52F-A5FD-40FE-9EE8-2C530DFC6B83Q35532072-BADF5916-C3AB-4DAF-ADCD-A16F1C14283DQ35602343-FAE612DC-C7CC-45AB-BE27-F7FE5909D804Q35643909-59F29558-372C-467B-95CB-56F394A92069Q35696499-F1C4C4AA-9EDA-4E60-BA79-7BC9D7ADC1A1Q35806135-9F70F44C-4CE3-4F36-ACEE-4C3E9B0EB56FQ35828434-DCAC80F6-4737-4552-A9F3-4A0C9DC96315Q35978114-D81926F2-468D-4391-BCE6-AE9A6D93BF45Q36147328-33FA2349-BBA2-4C1E-B751-691C32E7103DQ36157649-45047072-D5A6-4A75-81F1-3C6596AA9B35Q36234465-2229F112-6B0F-4CCC-9358-94CE5C86426BQ36398022-28E84961-F539-46D1-8D85-892E972281FB
P2860
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@ast
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@en
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@en-gb
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@nl
type
label
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@ast
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@en
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@en-gb
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@nl
prefLabel
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@ast
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@en
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@en-gb
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@nl
P2093
P3181
P356
P1433
P1476
The GPR55 ligand L-alpha-lysop ...... signaling and NFAT activation
@en
P2093
Andrew J Irving
Lesley A Ford
Maria Waldhoer
Ruth A Ross
P304
P3181
P356
10.1096/FJ.08-108670
P407
P577
2008-08-29T00:00:00Z